pI: 5.5094 |
Length (AA): 219 |
MW (Da): 25146 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
9 | 179 | 2gd5 (B) | 10 | 180 | 42.00 | 0.000000017 | 1 | 1.15952 | -0.07 |
12 | 211 | 5cwo (A) | 13 | 207 | 15.00 | 0 | 0.69 | 1.04164 | -0.63 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_129145)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G22950 | vacuolar protein sorting-associated protein 24-1 |
Brugia malayi | Bm1_56555 | SNF7 family protein |
Candida albicans | CaO19.9579 | sorting of proteins in pre-vacuolar endosome |
Candida albicans | CaO19.2031 | sorting of proteins in pre-vacuolar endosome |
Caenorhabditis elegans | CELE_T27F7.1 | Protein T27F7.1 |
Dictyostelium discoideum | DDB_G0284769 | SNF7 family protein |
Drosophila melanogaster | Dmel_CG9779 | Vacuolar protein sorting 24 |
Echinococcus granulosus | EgrG_000238400 | charged multivesicular body protein 3 |
Echinococcus multilocularis | EmuJ_000049300 | transfer RNA-Arg |
Echinococcus multilocularis | EmuJ_000238400 | charged multivesicular body protein 3 |
Echinococcus multilocularis | EmuJ_000048800 | transfer RNA-Ile |
Echinococcus multilocularis | EmuJ_000560500 | transfer RNA-Trp |
Homo sapiens | ENSG00000115561 | charged multivesicular body protein 3 |
Homo sapiens | ENSG00000249884 | RNF103-CHMP3 readthrough |
Leishmania braziliensis | LbrM.35.3670 | SNF7-like protein |
Leishmania donovani | LdBPK_363600.1 | Charged multivesicular body protein 3, putative |
Leishmania infantum | LinJ.36.3600 | SNF7-like protein |
Leishmania major | LmjF.36.3440 | SNF7-like protein |
Leishmania mexicana | LmxM.36.3440 | SNF7-like protein |
Loa Loa (eye worm) | LOAG_01290 | SNF7 family protein |
Mus musculus | ENSMUSG00000053119 | charged multivesicular body protein 3 |
Oryza sativa | 4331337 | Os03g0108400 |
Oryza sativa | 4343227 | Os07g0479400 |
Saccharomyces cerevisiae | YKL041W | ESCRT-III subunit protein VPS24 |
Schistosoma japonicum | Sjp_0133290 | IPR005024,Snf7,domain-containing |
Schistosoma japonicum | Sjp_0027500 | Charged multivesicular body protein 3, putative |
Schistosoma mansoni | Smp_032150 | neuroendocrine differentiation factor |
Schmidtea mediterranea | mk4.003826.01 | Charged multivesicular body protein 3 |
Trypanosoma brucei gambiense | Tbg972.11.11230 | class-E vacuolar protein-sorting protein 24 (Vps24p), putative,SNF7-like protein, putative |
Trypanosoma brucei | Tb927.11.10000 | Charged multivesicular body protein 3, putative |
Trypanosoma congolense | TcIL3000.11.10520 | Charged multivesicular body protein 3, putative |
Trypanosoma cruzi | TcCLB.503675.20 | class-E vacuolar protein-sorting protein 24 (Vps24p), putative |
Trypanosoma cruzi | TcCLB.506337.30 | Charged multivesicular body protein 3, putative |
Trichomonas vaginalis | TVAG_396200 | neuroendocrine differentiation factor, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.1760 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.1760 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.1760 this record | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.01.1760 this record | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_T27F7.1 | Caenorhabditis elegans | adult lethal | wormbase |
CELE_T27F7.1 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_T27F7.1 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_T27F7.1 | Caenorhabditis elegans | larval lethal | wormbase |
CELE_T27F7.1 | Caenorhabditis elegans | slow growth | wormbase |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | decreased (PATO:0000468) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in procyclic forms . | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
1 literature reference was collected for this gene.